Abeles

Biography

  Practiced medicine in London, before joining the pharmaceutical industry as a Senior Medical Executive with Sterling Drug, Pfizer, and Revlon Health Care. Became an industry analyst, and for over 35 years a prolific entrepreneur and venture investor. Played a key role in Encore Medical, acquired by Blackstone Capital; Newport Pharmaceuticals, acquired by Merck & Co.; Imre Corporation, acquired by Fresenius SE; ProCyte, acquired by PhotoMedex, and in many other public and private companies. Serves as an Advisory Board Member of the College of Chemistry, University of California, Berkeley and is a Fellow of the Royal Society of Medicine, London.   Practiced medicine in London, before joining the pharmaceutical industry as a Senior Medical Executive with Sterling Drug, Pfizer, and Revlon Health Care. Became an industry analyst, and for over 35 years a prolific entrepreneur and venture investor. Played a key role in Encore Medical, acquired by Blackstone Capital; Newport Pharmaceuticals, acquired by Merck & Co.; Imre Corporation, acquired by Fresenius SE; ProCyte, acquired by PhotoMedex, and in many other public and private companies. Serves as an Advisory Board Member of the College of Chemistry, University of California, Berkeley and is a Fellow of the Royal Society of Medicine, London.

Research Interest

Pharmaceutical Science